Determination of Glycemic Index (GI) of Ten Food Products

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier:
NCT01679704
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012

August 30, 2012
September 5, 2012
August 2012
November 2012   (final data collection date for primary outcome measure)
Glycemic index values of all ten products [ Time Frame: 120 minutes post adminstration ] [ Designated as safety issue: No ]
Glycemic index values at 120 minutes post adminstration.
Same as current
Complete list of historical versions of study NCT01679704 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Determination of Glycemic Index (GI) of Ten Food Products
Determination of Glycemic Index (GI) of Ten Food Products

This study is initiated to investigate the glycemic index value of ten food products.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Glycemic Index
Dietary Supplement: Food products
Food products
Ten food products will be given to all subjects
Intervention: Dietary Supplement: Food products
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
15
December 2012
November 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy non-pregnant females (at least 6 weeks postpartum, non-lactating)
  • Age between 21 to 60 years

Exclusion Criteria:

  • Suffering from any chronic diseases.
  • Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
  • History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
  • Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
  • Known food allergy or intolerance.
Female
21 Years to 60 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Singapore
 
NCT01679704
GIS.2012
No
Danone Asia Pacific Holdings Pte, Ltd.
Danone Asia Pacific Holdings Pte, Ltd.
Not Provided
Principal Investigator: Kalpana Bhaskaran, Dr Temasek Polytechnic
Danone Asia Pacific Holdings Pte, Ltd.
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP